Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APIXABAN Cause Upper gastrointestinal haemorrhage? 671 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 671 reports of Upper gastrointestinal haemorrhage have been filed in association with APIXABAN (ELIQUIS). This represents 0.4% of all adverse event reports for APIXABAN.

671
Reports of Upper gastrointestinal haemorrhage with APIXABAN
0.4%
of all APIXABAN reports
82
Deaths
525
Hospitalizations

How Dangerous Is Upper gastrointestinal haemorrhage From APIXABAN?

Of the 671 reports, 82 (12.2%) resulted in death, 525 (78.2%) required hospitalization, and 151 (22.5%) were considered life-threatening.

Is Upper gastrointestinal haemorrhage Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 671 reports have been filed with the FAERS database.

What Other Side Effects Does APIXABAN Cause?

Death (18,501) Cerebrovascular accident (7,237) Atrial fibrillation (5,690) Off label use (5,590) Thrombosis (5,298) Fall (5,063) Cardiac disorder (4,917) Haemorrhage (4,770) Dyspnoea (4,379) Gastrointestinal haemorrhage (4,030)

What Other Drugs Cause Upper gastrointestinal haemorrhage?

RIVAROXABAN (4,247) ASPIRIN (3,411) CLOPIDOGREL BISULFATE (1,265) DABIGATRAN ETEXILATE (861) IBUPROFEN (811) WARFARIN (610) NAPROXEN (445) DICLOFENAC (305) SERTRALINE (219) PREDNISOLONE (196)

Which APIXABAN Alternatives Have Lower Upper gastrointestinal haemorrhage Risk?

APIXABAN vs APOMORPHINE APIXABAN vs APRACLONIDINE APIXABAN vs APREMILAST APIXABAN vs APREPITANT APIXABAN vs APROTININ

Related Pages

APIXABAN Full Profile All Upper gastrointestinal haemorrhage Reports All Drugs Causing Upper gastrointestinal haemorrhage APIXABAN Demographics